Abstract
Renal denervation is a relatively recent concept whose initial promising results suffered a setback following the SYMPLICITY 3 trial, which did not show a significant blood pressure-lowering effect in comparison to sham. In this review article, we begin with the history including the physiological basis behind the concept of renal denervation. Furthermore, we review the literature in support of renal denervation, including the recently published SPYRAL HTN-OFF MED, which demonstrated significant blood pressure reduction in the absence of antihypertensive medication. We further touch upon the potential pitfalls and possible future directions of renal denervation.
Author supplied keywords
Cite
CITATION STYLE
Padmanabhan, D., Isath, A., & Gersh, B. (2018). Renal denervation: Paradise lost? Paradise regained? US Cardiology Review, 12(2), 78–86. https://doi.org/10.15420/usc.2018.1.2
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.